发明名称 Method of treating rhinitis with B-type and C-type natriuretic peptides
摘要 The problem to be solved by the present invention is to provide an effective and safe therapeutic preparation for rhinitis, which not only has significant effects on improvement in rhinitis, in particular allergic rhinitis, but also is rapid in manifestation of efficacy, fast-acting, and long-lasting, without local side effects.;Means for solving the problem is a therapeutic preparation for rhinitis, in particular allergic rhinitis, comprising C-type natriuretic peptide (CNP) or B-type natriuretic peptide (BNP) as the active ingredient.
申请公布号 US9358270(B2) 申请公布日期 2016.06.07
申请号 US201414193017 申请日期 2014.02.28
申请人 IGISU Co., Ltd. 发明人 Endo Kyoko
分类号 A61K38/22 主分类号 A61K38/22
代理机构 Wolf, Greenfield & Sacks, P.C. 代理人 Wolf, Greenfield & Sacks, P.C.
主权项 1. A method of treating rhinitis in a subject in need thereof comprising: administering to the subject a therapeutic preparation comprising C-type natriuretic peptide (CNP) or B-type natriuretic peptide (BNP) as the active ingredient, wherein the therapeutic preparation is a nasal drop preparation, and wherein a concentration of the C-type natriuretic peptide (CNP) or the B-type natriuretic peptide (BNP) is 10-500 μg/g in the therapeutic preparation, wherein CNP is selected from the group of consisting of CNP-22 and CNP-53, wherein the sequence of CNP-22 is SEQ ID NO: 1 and the sequence of CNP-53 is SEQ ID NO: 22, wherein BNP is selected from the group of consisting of BNP-26, BNP-32 and BNP-45, and wherein BNP-32 is SEQ ID NO: 2, the sequence of BNP-26 is SEQ ID NO: 23 and the sequence of BNP-45 is SEQ ID NO: 24 or SEQ ID NO: 25.
地址 Tokyo JP
您可能感兴趣的专利